810209X

C6-NBD Ceramide

Avanti Research^™ - A Croda Brand 810209X

• 別名: N-[6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl]-D-erythro-sphingosine:methanol (8:2)
• 実験式（ヒル表記法）: C₃₀H₄₉N₅O₆
• CAS番号: 94885-02-6
• 分子量: 575.74
• UNSPSCコード: 12352211
• NACRES: NA.25

特性

• アッセイ: >99% (TLC)
• 形状: liquid
• 包装: pkg of 1 × 1 mL (810209X-1mg)
• メーカー／製品名: Avanti Research^™ - A Croda Brand 810209X
• 濃度: 1 mg/mL (810209X-1mg)
• 輸送温度: dry ice
• 保管温度: −20°C
• InChI: 1S/C30H49N5O6/c1-2-3-4-5-6-7-8-9-10-11-12-13-15-18-27(37)25(23-36)32-28(38)19-16-14-17-22-31-24-20-21-26(35(39)40)30-29(24)33-41-34-30/h15,18,20-21,25,27,31,36-37H,2-14,16-17,19,22-23H2,1H3,(H,32,38)/b18-15+/t25-,27+/m0/s1
• InChI Key: HZIRBXILQRLFIK-VPZZKNKNSA-N

詳細

詳細

C6-NBD ceramide is a fluorescent labelled compound, known to be useful for the detection of enzymatic action. C6-NBD ceramide is preferred over radioactive compounds.

アプリケーション

C6-NBD Ceramide is suitable as a substrate for sphingomyelin synthase activity assay.

生物化学的／生理学的作用

Sphingolipid metabolism yields ceramide as one of the products. The family of ceramide synthases catalyses its synthesis. The ceramides differ in its acyl chain length. Ceramides possess a wide range of functions, associated with apoptosis, cancer inhibition and chemotherapy. Its action is also related to neurodegenerative diseases.

包装

5 mL Amber Glass Screw Cap Vial (810209X-1mg)

法的情報

Avanti Research is a trademark of Avanti Polar Lipids, LLC

安全性情報

• ピクトグラム: GHS02,GHS06,GHS08
• シグナルワード: Danger
• 危険有害性情報: H225,H302 + H312,H315,H319,H331,H336,H351,H361d,H370,H372
• 注意書き: P210 - P280 - P301 + P312 - P303 + P361 + P353 - P304 + P340 + P311 - P308 + P311
• 危険有害性の分類: Acute Tox. 3 Inhalation - Acute Tox. 4 Dermal - Acute Tox. 4 Oral - Carc. 2 - Eye Irrit. 2 - Flam. Liq. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 Oral - STOT SE 1 - STOT SE 3
• ターゲットの組織: Central nervous system, Eyes,Central nervous system, Liver,Kidney
• 保管分類コード: 3 - Flammable liquids
• WGK: WGK 3